Researchers look ahead to the potential uses and benefits of a technology that has been more than 20 years in the making. Researchers look ahead to the potential uses and benefits of a technology that has been more than 20 years in the making.
Navajo Catholics in the U.S. Southwest are expressing upset over a decision by the local Franciscan province to transfer administration of an historic mission founded some 125 years ago by St. Katharine Drexel.
New Jersey-based Seqirus today announced a new vaccine research and development facility will open in Massachusetts supporting the company's focus on a self-amplifying messenger RNA (sa-mRNA) technology platform, the next generation of mRNA technology. The new Waltham facility is expected to be fully operational by mid-2022.